Gene patents: a crowded IP field

Since the end of the first era of genome sequencing with the conclusion of the human genome project, the challenge facing the life sciences industry has been to apply our understanding to practical applications.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Regulation & Industry

UK unveils £1bn sector investment push after recent setbacks

30 October 2026 With its goal of becoming a global life sciences leader still some way off, the UK is betting on new investment, AI and regulatory changes to help close the gap, according to the government’s autumn budget.

Careers

Justice Joanna Smith appointed to interim High Court role as Sir Colin Birss replaces Sir Geoffrey Vos

30 October 2026 Mrs Justice Joanna Smith becomes deputy president of the Business and Property Division of the UK High Court, as Sir Colin Birss fills Sir Geoffrey Vos’ shoes as master of the rolls upon his retirement.

MedTech

Oura targets Ultrahuman’s redesigned smart ring following import ban

29 October 2026 The Finnish wearable tech company strikes again after the Indian rival’s redesigned ring cleared US Customs, with one of Oura’s asserted patents issued just two days earlier.

More features

Beyond the primary patent: How pharma can build competitive barriers

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

The UPC plugs another gap in its procedural rulebook

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

Abbott IP chief: ‘Firms without AI policies scare me’

Emotional Perception: What next for patent holders?

Gene patents: a crowded IP field

More on this story

Editor's picks

Editor's picks

More features